Skip to main content
PEN
NYSE Industrial Applications And Services

Penumbra Stockholders Approve $14.5B Merger with Boston Scientific

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$323.86
Mkt Cap
$12.748B
52W Low
$221.26
52W High
$362.41
52W Position info
46% above low
Off High info
11% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

PEN sits 46% above its 52-week low of $221.26.

Summary

Penumbra Inc. stockholders overwhelmingly approved the merger agreement with Boston Scientific, satisfying a key condition for the $14.5 billion acquisition.


Key Events · M&A and Partnerships · PEN

  • Merger Agreement Approved

    Penumbra's stockholders voted to adopt the Agreement and Plan of Merger with Boston Scientific Corporation, with 28,564,786 votes in favor.

  • Key Merger Condition Met

    The stockholder approval satisfies a critical condition for the consummation of the $14.5 billion merger.

  • Remaining Conditions Pending

    Consummation of the merger is still subject to other closing conditions, including antitrust and foreign investment approvals.


Analysis · PEN · Industrial Applications And Services

This 8-K formally reports the results of the special meeting where Penumbra's stockholders voted to adopt the merger agreement with Boston Scientific Corporation. The overwhelming approval of the merger proposal (over 99% of votes cast) is a critical step towards the consummation of the previously announced $14.5 billion acquisition, removing a significant shareholder-related hurdle. This filing adds specific vote details to the approval previously communicated via a 425 filing today. While this approval satisfies a major condition, the merger remains subject to other closing conditions, including regulatory clearances such as the Hart-Scott-Rodino Antitrust Improvements Act. Investors should monitor progress on these remaining conditions for the finalization of the deal.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PEN was trading at $323.86 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $12.7B. The 52-week trading range was $221.26 to $362.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PEN - Latest Insights

PEN
Jul 30, 2026, 4:44 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $317.55 info
Change: -$2.28 (-0.71%) info
Market Cap: $12.508B info
PEN
Jul 30, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $317.55 info
Change: -$2.28 (-0.71%) info
Market Cap: $12.508B info
PEN
Jul 30, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $317.55 info
Change: -$2.28 (-0.71%) info
Market Cap: $12.508B info
PEN
Jun 15, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $319.06
Real-time Price: $317.55 info
Change: -$1.51 (-0.47%) info
Market Cap: $12.508B info
PEN
Jun 11, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $318.32
Real-time Price: $317.55 info
Change: -$0.770 (-0.24%) info
Market Cap: $12.508B info